Monday, April 27, 2015

Kensey Nash, Cohen & Co. headline light month for shareholder meetings

Shareholders of the Exton-based Kensey Nash are being asked to approve an amendment to an incentive-pay plan.

Kensey Nash, Cohen & Co. headline light month for shareholder meetings

December could be considered the off-season for shareholder meetings.

Spring is when mailboxes bulge with thick proxy statements outlining the elections of directors and complex new incentive-pay plans. Last May, 65 local companies held their annual meetings. They were bracketed by 31 in April and 33 in June.

In contrast, December jingles with just four gatherings: Kensey Nash Corp. (Dec. 1), Cohen & Co. Inc. (Dec. 10), WPCS International Inc. and Discovery Laboratories Inc. (both Dec. 21).

Medical-device maker Kensey Nash has a short agenda for the meeting at its headquarters in Exton. One resolution seeks the reelection of a board member. Another seeks to ratify Deloitte & Touche L.L.P. as its independent auditor. But the third proposal may prove interesting because it involves amending an incentive-compensation plan that’s been around since 1995.

Kensey Nash’s board wants to add 300,000 shares to the plan, which has issued 3.4 million shares to key employees over 15 years. That’s a significant amount, given that the regenerative-medicine company had 8.5 million shares outstanding as of Oct. 22.

Two years ago, shareholders approved a similar amendment - increasing the shares available by 700,000 - with more than 8 million shares cast in favor. However, 2.5 million shares were voted against the plan.

After issuing its latest proxy statement on Nov. 1, the company said it was contacted by a corporate-governance firm, ISS Proxy Advisory Services, which indicated that it would recommend that shareholders vote against the amendment to the incentive-pay plan.

According to a filing with the Securities and Exchange Commission, Kensey Nash’s board made changes Nov. 18 to the proposal to address ISS’s concerns. We’ll see if shareholders are persuaded.

Shares of Kensey Nash are up 7.3 percent so far in 2010. But that gain lags the 74-member Standard & Poor’s 600 SmallCap Health-Care Index, which is up 14 percent this year. With a market value of $232 million, Kensey Nash is a member of that index.

Still, the company is profitable, with net income of $19.5 million, or $1.78 per share, on total revenues of $80.6 million for its fiscal year ended June 30. Those results were a little lower than the $20.1 million, or $1.69 per share, on revenues of $82.8 million for the year ended June 30, 2009.

Fedspeak

Elizabeth A. Duke, one of six current members of the board of governors of the Federal Reserve System, will be in Center City Thursday for a speech at the Federal Reserve Bank of Philadelphia.

The Philly Fed is holding an invitation-only conference over two days on recent legislative changes involving consumer credit and payments, and celebrating the 10th anniversary of its Payment Cards Center, a research group.

While organizers haven’t disclosed what she’ll be talking about, look for Duke, who joined the central bank board in August 2008, to stick with the event’s theme.

And that would mark a return to normalcy after a month of speeches by Fed chairman Ben Bernanke and other Fed officials defending the central bank’s latest efforts to reinflate the economy.

Inquirer Columnist
About this blog
Mike Armstrong blogs about Philadelphia corporations and business-related topics. Contact him at 215-854-2980. Reach Mike at marmstrong@phillynews.com.

Mike Armstrong Inquirer Columnist
Business Videos:
Also on Philly.com:
Stay Connected